Small-Scale Bioreactors Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Small-Scale Bioreactors Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Small-Scale Bioreactors Market:

https://www.thebusinessresearchcompany.com/report/small-scale-bioreactors-global-market-report

According to The Business Research Company’s Small-Scale Bioreactors Global Market Report 2024, The small-scale bioreactors market size has grown rapidly in recent years. It will grow from $1.9 billion in 2023 to $2.17 billion in 2024 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to research and development initiatives, rise in biopharmaceutical production, flexibility in process optimization, shift toward personalized medicine, increased focus on cell culture technologies..

The small-scale bioreactors market size is expected to see rapid growth in the next few years. It will grow to $3.73 billion in 2028 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to growing biopharmaceutical pipeline, rising adoption in regenerative medicine, expansion of contract development and manufacturing organizations (cdmos), advancements in microbial fermentation, increasing demand for flexible manufacturing solutions.. Major trends in the forecast period include rising demand for personalized medicine, growing importance of cell and gene therapies, emphasis on flexibility and scalability, integration of advanced monitoring and control systems, rise in outsourcing of bioproduction..

The rising prevalence of chronic diseases is expected to propel the growth of the small-scale bioreactors market going forward. A chronic disease is a form of illness that lasts three months or more and can deteriorate with time. Small-scale bioreactors are crucial for the development and optimization of processes; therefore, they are primarily used in pharmaceutical and biopharmaceutical research and help treat various chronic diseases. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least 1 chronic condition would increase to 142.66 million by 2050. Therefore, the rising prevalence of chronic diseases drives the growth of the small-scale bioreactors market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=10864&type=smp

The small-scale bioreactors market covered in this report is segmented –

1) By Product: Reusable Bioreactors, Single-Use Bioreactors

2) By Capacity: 5 ML-100 ML, 100 ML-250 ML, 250 ML -500 ML, 500 ML-1 L, 1L-3L, 3L-5L

3) By Molecules: Monoclonal Antibodies, Stem Cells, Recombinant Proteins, Vaccines, Gene Therapy

4) By End User: Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes

Product innovation is the key trend gaining popularity in the small-scale bioreactors market. Major companies operating in the small-scale bioreactors market are focusing on developing innovative products to sustain their position in the market. For instance, in October 2022, Froilabo, a France-based company specializing in manufacturing laboratory equipment, launched its new range of fully automated lab-scale bioreactors. This innovative product is designed for a variety of applications, including cell culture research and development, bioprocessing, fermentation, and wastewater treatment. It’s available in various sizes, from 1 liter to 100 liters, and is more efficient, easier to use, and more flexible. The bioprocess controller is straightforward and easy to use, allowing for high process oversight and control. This novel magnetically connected mixer avoids the potential of contamination within the vessel.

The small-scale bioreactors market report table of contents includes: